The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.
On Sept. 17, 2018, contract development and manufacturing organization Avista Pharma Solutions announced upgrades to its Agawam, MA, facility, increasing its analytical chemistry footprint while expanding its compendial and raw material testing capabilities. In addition to these upgrades, the company has also opened a new office in the Boston Metro area to provide broader cleanroom services and an expanded courier business.
The new office is an extension of the company’s microbiology, analytical, and cleanroom service offerings at its facility in Agawam. According to Avista Pharma, the most recent analytical service upgrades strengthens its pharmaceutical and medical device capabilities for microbiological and analytical testing. These upgrades include a new 950-ft2 laboratory space, which contributes to the expansion of its compendial and raw material testing capabilities.
In addition to the Agawam facility upgrades, Avista Pharma recently opened a new office in the Boston Metro area to support the company’s cleanroom service business. The company’s expanded courier service provides time- sensitive sample pickups from facilities throughout New England, delivering those samples daily to the Agawam facility for testing. Avista Pharma’s cleanroom service team supports cleanroom facilities for pharmaceuticals and medical devices, with services including risk assessments, generation of sampling plans, performance qualifications, International Organization for Standardization room certifications, and routine environmental monitoring.
Source: Avista Pharma Solutions
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.